0001209191-19-047633.txt : 20190828
0001209191-19-047633.hdr.sgml : 20190828
20190828180305
ACCESSION NUMBER: 0001209191-19-047633
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190826
FILED AS OF DATE: 20190828
DATE AS OF CHANGE: 20190828
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Banyai William
CENTRAL INDEX KEY: 0001753670
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38720
FILM NUMBER: 191063026
MAIL ADDRESS:
STREET 1: C/O TWIST BIOSCIENCE CORPORATION
STREET 2: 455 MISSION BAY BOULEVARD SOUTH
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Twist Bioscience Corp
CENTRAL INDEX KEY: 0001581280
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462058888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 455 MISSION BAY BOULEVARD SOUTH, SUITE 5
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 800-719-0671
MAIL ADDRESS:
STREET 1: 455 MISSION BAY BOULEVARD SOUTH, SUITE 5
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-08-26
0
0001581280
Twist Bioscience Corp
TWST
0001753670
Banyai William
C/O TWIST BIOSCIENCE CORPORATION
455 MISSION BAY BOULEVARD SOUTH
SAN FRANCISCO
CA
94158
1
1
0
0
Chief Operating Officer
Common Stock
2019-08-26
4
S
0
10487
27.911
D
736974
D
Common Stock
2019-08-26
4
S
0
513
28.465
D
736461
D
Common Stock
2019-08-27
4
S
0
7204
27.675
D
729257
D
Common Stock
2019-08-27
4
S
0
3796
28.319
D
725461
D
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
Represents the aggregate of sales effected on the same day at different prices.
Represents the weighted average sales price per share. The shares sold at prices ranging from $27.40 to $28.39 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Represents the weighted average sales price per share. The shares sold at prices ranging from $28.40 to $28.54 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average sales price per share. The shares sold at prices ranging from $27.14 to $28.13 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average sales price per share. The shares sold at prices ranging from $28.18 to $28.60 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
/s/ William Solis, as Attorney-in-Fact for William Banyai
2019-08-28